Literature DB >> 3068879

Detection of ras oncogenes by analysis of p21 proteins in human tumor cell lines.

J Fujita1, O Yoshida, Y Ebi, H Nakayama, H Onoue, J S Rhim, Y Kitamura.   

Abstract

To detect mutationally activated ras oncogenes, we analyzed electrophoretic mobilities of ras p21 proteins utilizing the fact that many ras oncogenes produce abnormal p21 proteins that migrate at SDS/polyacrylamide gel electrophoresis as a fast-moving or slow-moving species in comparison to a normal p21 depending on the kind of mutation. Of 18 human tumor cell lines analyzed, four (SW480, SW620 and SW403 colon cancers, and SW626 ovary cancer) produced p21 belonging to the slow-moving species, suggesting a point mutation within codon 12 of a member of the three ras genes, H-, Ki- and N-ras. Subsequent DNA transfection analysis using NIH/3T3 cells as recipients identified activated Ki-ras oncogenes in the same four but not in other 14 cell lines. Thus, the analysis of p21 might serve as a rapid primary method to screen a large number of tumor materials for the presence of certain types of mutationally activated ras oncogenes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3068879     DOI: 10.1007/bf00280021

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  18 in total

1.  Detection of high incidence of K-ras oncogenes during human colon tumorigenesis.

Authors:  K Forrester; C Almoguera; K Han; W E Grizzle; M Perucho
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

2.  Biological and biochemical properties of human rasH genes mutated at codon 61.

Authors:  C J Der; T Finkel; G M Cooper
Journal:  Cell       Date:  1986-01-17       Impact factor: 41.582

3.  Frequency of active ras oncogenes in human bladder cancers associated with schistosomiasis.

Authors:  J Fujita; H Nakayama; H Onoue; J S Rhim; M N el-Bolkainy; A A el-Aaser; Y Kitamura
Journal:  Jpn J Cancer Res       Date:  1987-09

Review 4.  The molecular genetics of cellular oncogenes.

Authors:  H E Varmus
Journal:  Annu Rev Genet       Date:  1984       Impact factor: 16.830

5.  Amino-acid substitutions at codon 13 of the N-ras oncogene in human acute myeloid leukaemia.

Authors:  J L Bos; D Toksoz; C J Marshall; M Verlaan-de Vries; G H Veeneman; A J van der Eb; J H van Boom; J W Janssen; A C Steenvoorden
Journal:  Nature       Date:  1985 Jun 27-Jul 3       Impact factor: 49.962

6.  Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene.

Authors:  D M Valenzuela; J Groffen
Journal:  Nucleic Acids Res       Date:  1986-01-24       Impact factor: 16.971

7.  Isolation of a new human oncogene from a diffuse B-cell lymphoma.

Authors:  A Eva; S A Aaronson
Journal:  Nature       Date:  1985 Jul 18-24       Impact factor: 49.962

8.  Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats.

Authors:  H Zarbl; S Sukumar; A V Arthur; D Martin-Zanca; M Barbacid
Journal:  Nature       Date:  1985 May 30-Jun 5       Impact factor: 49.962

9.  A human gastric carcinoma contains a single mutated and an amplified normal allele of the Ki-ras oncogene.

Authors:  J L Bos; M Verlaan-de Vries; C J Marshall; G H Veeneman; J H van Boom; A J van der Eb
Journal:  Nucleic Acids Res       Date:  1986-02-11       Impact factor: 16.971

10.  ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma.

Authors:  M V Viola; F Fromowitz; S Oravez; S Deb; J Schlom
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.